If they delivered the revised forecast, it would look very cheap. But that's a big "If" so soon in the year after a massive downgrade already.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025